In this episode of the Psychedelic Spotlight podcast we speak with the Founder & CEO of Kaivalya Kollectiv, Joël Brierre.
Similar Posts
Psychedelics, Neuroscience & Big Pharma – Interview with Rob Barrow | MindMed
In this episode of Psychedelic Spotlight, Matt sits down with…
MindCure CEO Kelsey Ramsden – The Psychedelic Space Is Unlike Any Other Drug Development Sector
In this interview with Kelsey Ramsden, CEO on MindCure Health…
Interview With Yaron Conforti, Novamind
In this episode, Psychedelic Spotlights, Director of Content, Jill Ettinger sits down with Chief Executive Officer, Director, and Co-Founder of Novamind, Yaron Conforti.
Interview with James Lanthier, CEO of Mindset Pharma
In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take the drug to clinical trials, and why next generation drugs are an important commercial opportunity for anyone looking to invest in the psychedelic sector.
Fixing Your Nervous System Dysregulation May Fix Your Anxiety and Depression with John Wood
In this episode, Sacha Hebbert and John Wood dive into a cautionary tale about the darker side of the psychedelic industry, where cults, and snake oil svengalis pray on open seekers all the time.
Psychedelic Decriminalization Update : Colorado, Oklahoma & Maine Move To Legalize Psychedelics?
Psychedelic Decriminalization Update Today, we take a look at 3…